Literature Review : Development of Monoclonal Antibodies Using The Expression System of Nicotiana benthamiana
DOI:
10.29303/jbt.v25i2.8919Published:
2025-05-30Downloads
Abstract
Monoclonal antibodies (mAbs) have become a key component in modern biotechnology and healthcare, playing essential roles in the treatment of diseases such as cancer, viral and bacterial infections, asthma, and in diagnostic applications. However, conventional mAb production using mammalian cell systems is costly, time-consuming, and presents scalability limitations. To address these challenges, current technological advances have led to the development of alternative platforms using plant-based expression systems. This review aims to explore the potential and progress in producing monoclonal antibodies through the Nicotiana benthamiana plant-based expression system, which offers several advantages including rapid production, cost efficiency, greater production capacity, and reduced risk of contamination. The method employed in this review is a literature study conducted through database searches (Google Scholar, PubMed, Science Direct, and others) focusing on peer-reviewed articles from 2015 to 2024. The articles were selected and then analyzed thematically was performed to extract relevant data. The results indicate that Nicotiana benthamiana can efficiently produce functional mAbs with glycosylation profiles comparable to mammalian systems. In addition, plant antibodies have also been successfully applied in various therapeutic and diagnostic studies. Further research is needed to ensure the safety and effectiveness of Nicotiana benthamiana plant-based mAb, as well as efforts to develop production scale for wider medical applications.
Keywords:
Antibody production, monoclonal antibodies, Nicotiana benthamiana, plant-based expression system.References
Boonyayothin, W., Kobtrakul, K., Khositanon, P., Vimolmangkang, S., & Phoolcharoen, W. (2022). Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application. Biotechnology Reports, 34(December 2021), 1-10. https://doi.org/10.1016/j.btre.2022.e00725
Diamos, A. G., Hunter, J. G. L., Pardhe, M. D., Rosenthal, S. H., Sun, H., Foster, B. C., DiPalma, M. P., Chen, Q., & Mason, H. S. (2020). High Level Production of Monoclonal Antibodies Using an Optimized Plant Expression System. Frontiers in Bioengineering and Biotechnology, 7(January), 1-15. https://doi.org/10.3389/fbioe.2019.00472
Do, V. G. (2023). Rapid Production of Cyclic Citrullinated Peptide Monoclonal Antibody in Nicotiana benthamiana for the Early Detection and Diagnosis of Rheumatoid Arthritis. SynBio, 1(1), 103–115. https://doi.org/10.3390/synbio1010008
Frigerio, R., Marusic, C., Villani, M. E., Lico, C., Capodicasa, C., Andreano, E., Paciello, I., Rappuoli, R., Salzano, A. M., Scaloni, A., Baschieri, S., & Donini, M. (2022). Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana. Frontiers in Plant Science, 13.(September), 1-14 https://doi.org/10.3389/fpls.2022.956741
Goulet, M. C., Gaudreau, L., Gagné, M., Maltais, A. M., Laliberté, A. C., Éthier, G., Bechtold, N., Martel, M., D’Aoust, M. A., Gosselin, A., Pepin, S., & Michaud, D. (2019). Production of biopharmaceuticals in Nicotiana benthamiana axillary stem growth as a key determinant of total protein yield. Frontiers in Plant Science, 10(June). 1-9 https://doi.org/10.3389/fpls.2019.00735
Hanittinan, O., Rattanapisit, K., Malla, A., Tharakhet, K., Ketloy, C., Prompetchara, E., & Phoolcharoen, W. (2022). Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies. Frontiers in Plant Science, 13(December), 1–12. https://doi.org/10.3389/fpls.2022.1012583
Hiatt, A., Whaley, K. J., & Zeitlin, L. (2015). Plant-derived monoclonal antibodies for prevention and treatment of infectious disease. Antibodies for Infectious Diseases, 411–425. https://doi.org/10.1128/9781555817411.ch24
Hurtado, J., Acharya, D., Lai, H., Sun, H., Kallolimath, S., Steinkellner, H., Bai, F., & Chen, Q. (2020). In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants. Plant Biotechnology Journal, 18(1), 266–273. https://doi.org/10.1111/pbi.13194
Husk, A., Hamorsky, K. T., & Matoba, N. (2016). Monoclonal Antibody Purification (Nicotiana benthamiana Plants). Bio Protoc, 176(1), 1–7, e1034-e1034.
Krittanai, S., Rattanapisit, K., Bulaon, C. J. I., Pitaksajjakul, P., Keadsanti, S., Ramasoota, P., Strasser, R., & Phoolcharoen, W. (2024). Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody. Biotechnology Reports, 42(May), 1-9. https://doi.org/10.1016/j.btre.2024.e00844
Li, J., Stoddard, T. J., Demorest, Z. L., Lavoie, P. O., Luo, S., Clasen, B. M., Cedrone, F., Ray, E. E., Coffman, A. P., Daulhac, A., Yabandith, A., Retterath, A. J., Mathis, L., Voytas, D. F., D’Aoust, M. A., & Zhang, F. (2016). Multiplexed, targeted gene editing in Nicotiana benthamiana for glyco-engineering and monoclonal antibody production. Plant Biotechnology Journal, 14(2), 533–542. https://doi.org/10.1111/pbi.12403
Morel, B., Favrot, C., Mirande, L., Grünwald-Gruber, C., Stordeur, V., Vezina, L. P., Faye, L., & Gomord, V. (2024). Exploring the Potentiality of a Plant Platform for Monoclonal Antibody Production in Veterinary Medicine. Vaccines, 12(6), 1–17. https://doi.org/10.3390/vaccines12060620
Ocampo, C. G., Lareu, J. F., Marin Viegas, V. S., Mangano, S., Loos, A., Steinkellner, H., & Petruccelli, S. (2016). Vacuolar targeting of recombinant antibodies in Nicotiana benthamiana. Plant Biotechnology Journal, 14(12), 2265–2275. https://doi.org/10.1111/pbi.12580
Phakham, T., Bulaon, C. J. I., Khorattanakulchai, N., Shanmugaraj, B., Buranapraditkun, S., Boonkrai, C., Sooksai, S., Hirankarn, N., Abe, Y., Strasser, R., Rattanapisit, K., & Phoolcharoen, W. (2021). Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System. Frontiers in Plant Science, 12(September), 1–13. https://doi.org/10.3389/fpls.2021.736299
Pisuttinusart, N., Rattanapisit, K., Srisaowakarn, C., Thitithanyanont, A., Strasser, R., Shanmugaraj, B., & Phoolcharoen, W. (2024). Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana. Human Vaccines and Immunotherapeutics, 20(1), 1–10. https://doi.org/10.1080/21645515.2024.2327142
Rattanapisit, K., Phakham, T., Buranapraditkun, S., Siriwattananon, K., Boonkrai, C., Pisitkun, T., Hirankarn, N., Strasser, R., Abe, Y., & Phoolcharoen, W. (2019). Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody. Scientific Reports, 9(1), 1–10. https://doi.org/10.1038/s41598-019-51656-1
Sangprasat, K., Bulaon, C. J. I., Rattanapisit, K., Srisangsung, T., Jirarojwattana, P., Wongwatanasin, A., & Phoolcharoen, W. (2024). Production of monoclonal antibodies against botulinum neurotoxin in Nicotiana benthamiana. Human Vaccines and Immunotherapeutics, 20(1), 1-11. https://doi.org/10.1080/21645515.2024.2329446
Shanmugaraj, B., Rattanapisit, K., Manopwisedjaroen, S., Thitithanyanont, A., & Phoolcharoen, W. (2020). Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro. Frontiers in Plant Science, 11(November), 1–11. https://doi.org/10.3389/fpls.2020.589995
Steinebach, F., Ulmer, N., Wolf, M., Decker, L., Schneider, V., Wälchli, R., Karst, D., Souquet, J., & Morbidelli, M. (2017). Design and operation of a continuous integrated monoclonal antibody production process. Biotechnology Progress, 33(5), 1303–1313. https://doi.org/10.1002/btpr.2522
Swope, K., Morton, J., Pogue, G. P., Burden, L., Partain, N., Hume, S., Shepherd, J., Simpson, C. A., Brennan, M. B., Furman, T. C., Kingrey-Gebe, S., Martinez, T., McDonough, J., Pauly, M. H., Whaley, K. J., Zeitlin, L., Bratcher, B., & Haydon, H. (2022). Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana. MAbs, 14(1), 1–13. https://doi.org/10.1080/19420862.2021.2013594
License
Copyright (c) 2025 Audina Filsa Nur Anugraheni, Imasayu Nuralyza, Dinda Ayu Maulira, Aliza Salsabila Ramadhani, Baiq Dwiyan Nugrahani, Anggit Listyacahyani Sunarwidhi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
